Advancing the Next Parkinson’s Disease Breakthrough: Keys to Successful Clinical Trials

Parkinson’s disease (PD) affects more than 6 million people worldwide, yet the gold-standard treatment was approved over 30 years ago.1,2 With a robust early-stage pipeline, the absence of new, transformative treatments is not the result of a lack of interest but of the high failure rate following Phase II clinical trials.3 So, how can developers increase their probability of success?

To propel the field toward its next breakthrough, success hinges on trial designs that reflect the complexities of PD and accommodate the varying needs of patients.

In this webinar, the featured speakers will explore essential strategies for executing successful PD clinical trials. Topics will include collaborating with patient advocacy groups, using innovative study designs, selecting the appropriate symptom scales and protecting study endpoints. At the heart of it all: putting the patient first.

Register for this webinar to learn how to improve success in PD clinical trials through patient-centric and data-driven design.

Speakers

Antonio Hernandez, PsyD, Vice President, Program Strategy, Neuroscience, Premier Research

Melissa Snyder, PhD, Executive Director, Program Strategy, Neuroscience, Premier Research